Narrative review / 2014
A review indicates DHEA supplementation may offer immunomodulatory, musculoskeletal, and metabolic benefits in certain human populations.
This review evaluates evidence regarding dehydroepiandrosterone (DHEA) supplementation. Double-blind, placebo-controlled human trials in the elderly show DHEA increases monocytes, TCRγδ T cells, and NK cells, while improving well-being, muscle strength, bone density, and reducing body fat and skin atrophy. In adrenal insufficiency, it restores hormone levels, lowers total cholesterol, improves insulin sensitivity, and preserves bone mineral density. In women, DHEA improves sexual satisfaction, fertility, and vaginal atrophy, though studies remain inconsistent due to dosing differences, rapid metabolism, and other factors.
- Study type
- Narrative review
- Who was studied
- Humans across various conditions (e.g., elderly, adrenal insufficiency)
- What was measured
- Effects of DHEA on immune markers, well-being, body composition, and disease states
THE PAPER
Dehydroepiandrosterone (DHEA): hypes and hopes.
Rutkowski K, Sowa P, Rutkowska-Talipska J, Kuryliszyn-Moskal A, Rutkowski R. Drugs, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.